Cfo4 Life Group, LLC Novartis Ag Transaction History
Cfo4 Life Group, LLC
- $648 Million
- Q3 2025
A detailed history of Cfo4 Life Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 5,697 shares of NVS stock, worth $749,440. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,697
Previous 5,551
2.63%
Holding current value
$749,440
Previous $671,000
8.79%
% of portfolio
0.11%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...